CSat Investment Advisory’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
CSat Investment Advisory's AMGN Position: Q1 2021 in Review
CSat Investment Advisory increased its Amgen (AMGN) stake by 17,990% in Q1 2021, buying an estimated $859K and bringing the position to 3,618 shares worth $900K. The position accounts for 0.76% of the portfolio, ranked #51.
CSat Investment Advisory first reported a position in AMGN in Q2 2018 and has held it in 12 quarters since. 2,219 funds tracked by Wall St. Rank hold AMGN as of Q1 2021.
- CSat Investment Advisory held 3,618 shares of Amgen worth $900K as of Q1 2021.
- CSat Investment Advisory bought 3,598 Amgen shares in Q1 2021, an estimated $859K.
- Amgen made up 0.76% of CSat Investment Advisory's portfolio in Q1 2021, its #51 holding.
- CSat Investment Advisory first reported a position in Amgen in Q2 2018 and has held it in 12 quarters since.
- 2,219 funds tracked by Wall St. Rank held Amgen as of Q1 2021.
Based on CSat Investment Advisory's 13F filing for Q1 2021, filed 13 May 2021.